Sanrox 0.25mg Injection
Marketer
Sanzyme Ltd
Salt Composition
Cetrorelix (0.25mg)
Overview Sanrox 0.25mg Injection
GnRH antagonist Sanrox, administered as a 0.25mg injection, aids in female infertility treatment. Its mechanism involves suppressing premature egg release. Administered subcutaneously by a healthcare professional, self-injection is contraindicated. Guidance on proper at-home injection technique will be provided. Dosage and frequency are determined by your physician based on individual needs and treatment goals. Continue using this medication as directed. Common side effects include injection site reactions (redness, itching, irritation), nausea, and vomiting. Rotate injection sites (e.g., abdomen) daily to minimize irritation. Seek immediate medical attention for dizziness, fainting, abdominal pain, or severe vomiting. Prior to treatment, inform your doctor of any pre-existing liver or kidney conditions, breastfeeding status, and all other medications you are currently using, as interactions may affect Sanrox's efficacy.
Primary Ingredients of Sanrox 0.25mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Sanrox 0.25mg Injection
Inability to conceive in women
Major Benefits of Sanrox 0.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Sanrox 0.25mg Injection:
- Nausea
- Ovarian hyperstimulation syndrome
- Injection site reactions (pain, swelling, redness)
- Itching
- Irritation
- Vomiting
- Lower abdominal pain
How to use Sanrox 0.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Sanrox 0.25mg Injection works:
Women with infertility receiving treatment may experience premature egg release, yielding oocytes unsuitable for conception. Sanrox 0.25mg Injection inhibits a key hormone, thereby preventing premature ovarian follicle rupture.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Sanrox 0.25mg Injection necessitates caution. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Sanrox 0.25mg Injection to pregnant individuals poses a substantial risk. Pregnant women should consult their physician before use, as research in both animal and human subjects has revealed considerable adverse effects on fetal development.
Breast feedingUNSAFE
Administration of Sanrox 0.25mg Injection is contraindicated during lactation. Available evidence indicates potential infant toxicity.
DrivingSAFE
Driving ability is typically unaffected by Sanrox 0.25mg Injection.
KidneyCAUTION
Patients with kidney impairment should receive Sanrox 0.25mg Injection cautiously, potentially requiring a modified dosage. Physician consultation is advised. Sanrox 0.25mg Injection is contraindicated for individuals with severely compromised kidney function.
LiverCAUTION
Patients with hepatic impairment should use Sanrox 0.25mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Sanrox 0.25mg Injection :
Omit Sanrox 0.25mg Injection doses require physician consultation.
Facts to Know About Sanrox 0.25mg Injection
| Label | Value |
|---|---|
| Chemical Type | Peptide chains |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Action Class | GnRH receptor blockers |
3,018 People bought this recently